Primaquine for plasmodium vivax malaria treatment – authors' reply by Price, RN, Taylor, WRJ, Thriemer, K, White, NJ, Day, NP

Why is WHO failing women with falciparum malaria in the first trimester of pregnancy? by McGready, R, Nosten, F, Barnes, KI, Mokuolu, O, White, NJ

Survival of Burkholderia pseudomallei and pathogenic Leptospira in cola, beer, energy drinks, and sports drinks by Wuthiekanun, V, Amornchai, P, Langla, S, White, NJ, Day, NPJ, Limmathurotsakul, D

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria by Tarning, J, von Seidlein, L, Dondorp, AM, White, NJ, Maude, RJ

Infectivity of chronic malaria infections and its consequences for control and elimination by Aguas, RJA, Maude, RJ, Gomes, MGM, White, LJ, White, NJ, Dondorp, AM

A systematic review of neglected tropical diseases (NTDs) in Myanmar by Swe, MMM, Phyo, AP, Cooper, BS, White, NJ, Smithuis, F, Ashley, EA

The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions by Schilling, WHK, Callery, JJ, Chandna, A, Hamers, RL, Watson, J, White, NJ

A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency. by Boonyuen, U, Chamchoy, K, Swangsri, T, Junkree, T, Day, NPJ, White, NJ, Imwong, M

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology by White, NJ, Watson, JA, Hoglund, RM, Chan, XHS, Cheah, PY, Tarning, J

Polymorphic markers for identification of parasite population in Plasmodium malariae by Mathema, VB, Nakeesathit, S, Pagornrat, W, Smithuis, F, White, NJ, Dondorp, AM, Imwong, M

A cautionary note on the use of unsupervised machine learning algorithms to characterise malaria parasite population structure from genetic distance matrices by Watson, JA, Taylor, AR, Ashley, EA, Dondorp, A, Buckee, CO, White, NJ, Holmes, CC

Improving the diagnosis of severe malaria in African children using platelet counts and plasma Pf HRP2 concentrations by Williams, T, Watson, J, Uyoga, S, Wanjiku, P, Woodrow, CJ, Day, N, Bejon, P, White, NJ

An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria. by Saralamba, S, Simpson, JA, Choosri, N, White, L, Pan-Ngum, W, Dondorp, AM, White, NJ

Antimalarial mass drug administration in large populations and the evolution of drug resistance by Nguyen, TD, Tran, TN-A, Tran, TN-A, Parker, DM, White, NJ, Boni, MF

Concentration-dependent mortality of chloroquine in overdose by Watson, JA, Tarning, J, Hoglund, RM, Baud, FJ, Megarbane, B, Clemessy, J-L, White, NJ

Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis by Guérin, PJ, McLean, ARD, Rashan, S, Lawal, A, Watson, JA, Strub-Wourgaft, N, White, NJ

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria? by van der Pluijm, RW, Peto, TJ, Hamaluba, M, Callery, JJ, Tripura, R, White, NJ, Dondorp, AM

Bactericidal activities and post-antibiotic effects of ofloxacin and ceftriaxone against drug-resistant Salmonella enterica serovar Typhi by Wain, J, Simpson, JA, Luong, TDN, To, SD, Pham, TD, Baker, S, Day, NPJ, White, NJ, Parry, CM

Utility of Plasmodium falciparum DNA from rapid diagnostic test kits for molecular analysis and whole genome amplification by Srisutham, S, Suwannasin, K, Mathema, VB, Sriprawat, K, Smithuis, FM, Nosten, F, White, NJ, Dondorp, AM, Imwong, M

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine by Whittaker, DG, Capel, RA, Hendrix, M, Chan, XHS, Herring, N, White, NJ, Mirams, GR, Burton, R-AB